Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), Subcommittee on Dose Reconstruction Review (SDRR), National Institute for Occupational Safety and Health (NIOSH), 26288-26289 [2018-12149]
Download as PDF
daltland on DSKBBV9HB2PROD with NOTICES
26288
Federal Register / Vol. 83, No. 109 / Wednesday, June 6, 2018 / Notices
safety and health education,
ergonomics, epidemiology, biostatistics,
and psychology. Federal employees will
not be considered for membership.
Members may be invited to serve for up
to four-year terms. Selection of members
is based on candidates’ qualifications to
contribute to the accomplishment of the
board’s objectives https://www.cdc.gov/
niosh/BSC/default.html.
DATES: Nominations for membership on
the BSC must be received no later than
August 1, 2018. Packages received after
this time will not be considered for the
current membership cycle.
ADDRESSES: All nominations should be
mailed to NIOSH Docket 278, c/o
Pauline Benjamin, Committee
Management Specialist, National
Institute for Occupational Safety and
Health, Centers for Disease Control and
Prevention, 1600 Clifton Rd. NE, MS:
E–20, Atlanta, Georgia 30329, or
emailed (recommended) to
nioshdocket@cdc.gov.
FOR FURTHER INFORMATION CONTACT:
Alberto Garcia, M.S., DFO, CDC/NIOSH,
1090 Tusculum Ave. MS R–5,
Cincinnati, OH 45226, telephone (513)
841–4596; agarcia1@cdc.gov.
SUPPLEMENTARY INFORMATION: The U.S.
Department of Health and Human
Services policy stipulates that
committee membership be balanced in
terms of points of view represented, and
the committee’s function. Appointments
shall be made without discrimination
on the basis of age, race, ethnicity,
gender, sexual orientation, gender
identity, HIV status, disability, and
cultural, religious, or socioeconomic
status. Nominees must be U.S. citizens,
and cannot be full-time employees of
the U.S. Government. Current
participation on federal workgroups or
prior experience serving on a federal
advisory committee does not disqualify
a candidate; however, HHS policy is to
avoid excessive individual service on
advisory committees and multiple
committee memberships. Committee
members are Special Government
Employees (SGEs), requiring the filing
of financial disclosure reports at the
beginning and annually during their
terms. CDC reviews potential candidates
for NIOSH BSC membership each year,
and provides a slate of nominees for
consideration to the Secretary of HHS
for final selection. HHS notifies selected
candidates of their appointment near
the start of the term in January 2019, or
as soon as the HHS selection process is
completed. Note that the need for
expertise varies from year to year and a
candidate who is not selected in one
year may be reconsidered in a
subsequent year. SGE Nominees must be
VerDate Sep<11>2014
17:35 Jun 05, 2018
Jkt 244001
U.S. citizens, and cannot be full-time
employees of the U.S. Government.
Candidates should submit the following
items:
D Current curriculum vitae, including
complete contact information (telephone
numbers, mailing address, email address).
D At least one letter of recommendation
from person(s) not employed by the U.S.
Department of Health and Human Services.
(Candidates may submit letter(s) from current
HHS employees if they wish, but at least one
letter must be submitted by a person not
employed by an HHS agency (e.g., CDC, NIH,
FDA, etc.).
Nominations may be submitted by the
candidate him- or herself, or by the
person/organization recommending the
candidate. The Director, Management
Analysis and Services Office, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Elaine Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2018–12150 Filed 6–5–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH or the
Advisory Board), Subcommittee on
Dose Reconstruction Review (SDRR),
National Institute for Occupational
Safety and Health (NIOSH)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Subcommittee for Dose
Reconstruction Reviews (SDRR) of the
Advisory Board on Radiation and
Worker Health (ABRWH). This meeting
is open to the public, but without a
public comment period. The public is
welcome to submit written comments in
advance of the meeting, to the contact
person below. Written comments
received in advance of the meeting will
be included in the official record of the
meeting. The public is also welcome to
listen to the meeting by joining the
teleconference at the USA toll-free, dial-
SUMMARY:
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
in number at 1–866–659–0537; the pass
code is 9933701. The conference line
has 150 ports for callers.
DATES: The meeting will be held on July
24, 2018, 10:30 a.m. to 4:30 p.m. EDT.
ADDRESSES: Audio Conference Call via
FTS Conferencing. The USA toll-free
dial-in number is 1–866–659–0537; the
pass code is 9933701.
FOR FURTHER INFORMATION CONTACT:
Theodore Katz, MPA, Designated
Federal Officer, NIOSH, CDC, 1600
Clifton Road, Mailstop E–20, Atlanta,
Georgia 30329, Telephone (513)533–
6800, Toll Free 1(800)CDC–INFO, Email
ocas@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that
have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule; advice on
methods of dose reconstruction, which
have also been promulgated by HHS as
a final rule; advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program; and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to CDC. NIOSH
implements this responsibility for CDC.
The charter was issued on August 3,
2001, renewed at appropriate intervals,
rechartered on February 12, 2018,
pursuant to Executive Order 13708, and
will terminate on September 30, 2019.
Purpose: The Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at
any Department of Energy facility who
were exposed to radiation but for whom
it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
E:\FR\FM\06JNN1.SGM
06JNN1
Federal Register / Vol. 83, No. 109 / Wednesday, June 6, 2018 / Notices
the health of members of this class.
SDRR was established to aid the
Advisory Board in carrying out its duty
to advise the Secretary, HHS, on dose
reconstruction.
Matters To Be Considered: The agenda
will include discussions on the
following dose reconstruction program
quality management and assurance
activities: Dose reconstruction cases
under review from Sets 19—24,
including Iowa Ordinance Plant,
Nevada Test Site, Los Alamos National
Laboratory, Feeds Material Production
Center (Fernald), Pantex Plant, Rocky
Flats Plant, W.R. Grace, Hanford,
Savannah River Site, Fernald, GE
Evendale, Texas City Chemicals, Canoga
Avenue Facility, De Soto Avenue
Facility, Pacific Northwest National
Laboratory, Amchitka Island Nuclear
Explosion Site, Oak Ridge facilities,
Paducah Gaseous Diffusion Plant, and
potentially other Department of Energy
and Atomic Weapons Employers
facilities.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2018–12149 Filed 6–5–18; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–18–0920; Docket No. CDC–2018–
0053]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
daltland on DSKBBV9HB2PROD with NOTICES
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
SUMMARY:
VerDate Sep<11>2014
17:35 Jun 05, 2018
Jkt 244001
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Data Collection Through Web
Based Surveys for Evaluating Act
Against AIDS Social Marketing
Campaign Phases Targeting Consumers
which includes web surveys to test
campaign messaging.
DATES: CDC must receive written
comments on or before August 6, 2018.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2018–
0053 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Leroy A.
Richardson, Information Collection
Review Office, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, MS–D74, Atlanta, Georgia
30329; phone: 404–639–7570; Email:
omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
26289
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Data Collection Through Web Based
Surveys for Evaluating Act Against
AIDS Social Marketing Campaign
Phases Targeting Consumers—
Extension—National Center for HIV/
AIDS, Viral Hepatitis, STD and TB
Prevention (NCHHSTP, Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
In response to the continued HIV
epidemic in our country, CDC launched
Act Against AIDS (AAA), a multifaceted
communication campaign to reduce HIV
incidence in the United States in 2009.
CDC has released the campaign in
phases, with some of the phases running
concurrently. Each phase of the
campaign uses mass media and directto-consumer channels to deliver
messages. Some campaigns provide
basic education and increase awareness
of HIV/AIDS among the general public
whereas others emphasize HIV
prevention and testing among specific
subgroups or communities at greatest
risk of infection. CDC will also develop
new messages to address changes in
prevention science and subpopulations
affected by HIV. The proposed study
will assess the effectiveness of these
social marketing messages aimed at
increasing HIV/AIDS awareness,
increasing prevention behaviors, and
improving HIV testing rates among
consumers.
This extension of an ongoing study
will allow for continued evaluation of
the effectiveness of AAA social
marketing campaign through surveys
with consumers. A total of 10,750
respondents were approved for the
previously renewed generic ICR (0920–
0920) and since the approval date, 4,305
respondents were surveyed under the
GenIC, ‘‘Development of Messages for
E:\FR\FM\06JNN1.SGM
06JNN1
Agencies
[Federal Register Volume 83, Number 109 (Wednesday, June 6, 2018)]
[Notices]
[Pages 26288-26289]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-12149]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health (ABRWH or the
Advisory Board), Subcommittee on Dose Reconstruction Review (SDRR),
National Institute for Occupational Safety and Health (NIOSH)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Subcommittee for Dose
Reconstruction Reviews (SDRR) of the Advisory Board on Radiation and
Worker Health (ABRWH). This meeting is open to the public, but without
a public comment period. The public is welcome to submit written
comments in advance of the meeting, to the contact person below.
Written comments received in advance of the meeting will be included in
the official record of the meeting. The public is also welcome to
listen to the meeting by joining the teleconference at the USA toll-
free, dial-in number at 1-866-659-0537; the pass code is 9933701. The
conference line has 150 ports for callers.
DATES: The meeting will be held on July 24, 2018, 10:30 a.m. to 4:30
p.m. EDT.
ADDRESSES: Audio Conference Call via FTS Conferencing. The USA toll-
free dial-in number is 1-866-659-0537; the pass code is 9933701.
FOR FURTHER INFORMATION CONTACT: Theodore Katz, MPA, Designated Federal
Officer, NIOSH, CDC, 1600 Clifton Road, Mailstop E-20, Atlanta, Georgia
30329, Telephone (513)533-6800, Toll Free 1(800)CDC-INFO, Email
[email protected].
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing advice
on the development of probability of causation guidelines that have
been promulgated by the Department of Health and Human Services (HHS)
as a final rule; advice on methods of dose reconstruction, which have
also been promulgated by HHS as a final rule; advice on the scientific
validity and quality of dose estimation and reconstruction efforts
being performed for purposes of the compensation program; and advice on
petitions to add classes of workers to the Special Exposure Cohort
(SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3, 2001,
renewed at appropriate intervals, rechartered on February 12, 2018,
pursuant to Executive Order 13708, and will terminate on September 30,
2019.
Purpose: The Advisory Board is charged with (a) providing advice to
the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and (c) upon request by the Secretary, HHS,
advise the Secretary on whether there is a class of employees at any
Department of Energy facility who were exposed to radiation but for
whom it is not feasible to estimate their radiation dose, and on
whether there is reasonable likelihood that such radiation doses may
have endangered
[[Page 26289]]
the health of members of this class. SDRR was established to aid the
Advisory Board in carrying out its duty to advise the Secretary, HHS,
on dose reconstruction.
Matters To Be Considered: The agenda will include discussions on
the following dose reconstruction program quality management and
assurance activities: Dose reconstruction cases under review from Sets
19--24, including Iowa Ordinance Plant, Nevada Test Site, Los Alamos
National Laboratory, Feeds Material Production Center (Fernald), Pantex
Plant, Rocky Flats Plant, W.R. Grace, Hanford, Savannah River Site,
Fernald, GE Evendale, Texas City Chemicals, Canoga Avenue Facility, De
Soto Avenue Facility, Pacific Northwest National Laboratory, Amchitka
Island Nuclear Explosion Site, Oak Ridge facilities, Paducah Gaseous
Diffusion Plant, and potentially other Department of Energy and Atomic
Weapons Employers facilities.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2018-12149 Filed 6-5-18; 8:45 am]
BILLING CODE 4163-19-P